Clinical trial Recruiting at 6 sites Phase 4 Interventional Ages 18 and up

Screening mammograms with or without AI assistance for breast cancer detection

Official title: A Randomized Controlled Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Run by Jonsson Comprehensive Cancer Center · NCT06934239 · Data updated 2026-11-12

This trial will try using an FDA-cleared AI tool to help radiologists read screening mammograms for adults to see if it finds more cancers and reduces unnecessary callbacks.

More Breast Cancer Screening trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment400000 (estimated)
SponsorJonsson Comprehensive Cancer Center
Academic / other
Locations6 sites (Los Angeles, California and 5 other locations)
StatusRecruiting
StartedOctober 15, 2025
Main results expectedMarch 1, 2028
Study endsMarch 1, 2030
Registry record updatedNovember 9, 2026
Trial IDNCT06934239 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who receive routine screening mammograms at one of the participating breast imaging facilities (and the radiologists who interpret those exams) are eligible to participate.

Probably not a fit

People who are getting diagnostic (not screening) mammograms, who are screened outside the participating sites, or who have opted out of research will not be included and therefore will not directly benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a multisite, real-world randomized trial, individual screening mammography exams are randomly assigned to be interpreted with the AI decision-support tool turned on or off at the exam level. Randomization occurs automatically shortly after image acquisition so radiologists cannot sort exams by AI availability, and patients returning in year two may be re-randomized. The design captures many interpretations with and without AI for each radiologist, allowing measurement of both population-level effects on cancer detection and recall rates and a radiologist-level learning curve. Participating sites include six regional U.S. health systems and all adult screening mammograms at those facilities during the trial period are included unless a patient has opted out of research.

Why it matters

Potential benefit: If successful, the AI tool could help detect more cancers earlier and reduce unnecessary follow-up imaging and recalls.

How similar studies have gone: Prior research and some FDA-cleared AI tools have shown promise for improving cancer detection and altering recall rates, but large multicenter, exam-level randomized trials in real-world U.S. settings remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
This trial will include all radiologists interpreting screening mammography and all adult patients undergoing screening mammography at any of the participating breast imaging facilities across 6 regional health systems (UCLA, UC San Diego, University of Washington-Seattle, University of Wisconsin-Madison, Boston Medical Center, and University of Miami) during the trial period. Individuals must meet the following eligiblity criteria.

Inclusion Criteria:

1. Be at least 18 years of age or older
2. Receive a screening mammogram at one of the participating breast imaging facilities OR be a radiologist who interprets screening mammograms at one of the participating breast imaging facilities.

Exclusion Criteria:

1\. Patients who have opted out of all research at the health system

Where it's running

  • University of California Los Angeles Health System
    Los Angeles, California, United States
    Recruiting
  • University of California, San Diego
    San Diego, California, United States
    Recruiting
  • University of Miami Health System
    Miami, Florida, United States
    Recruiting
  • Boston Medical Center
    Boston, Massachusetts, United States
    Recruiting
  • University of Washington Health System
    Seattle, Washington, United States
    Recruiting
  • University of Wisconsin-Madison
    Madison, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.